Filing Details
- Accession Number:
- 0001280776-16-000016
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-08-15 09:23:31
- Reporting Period:
- 2016-08-11
- Filing Date:
- 2016-08-15
- Accepted Time:
- 2016-08-15 09:23:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1280776 | Vital Therapies Inc | VTL | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1352620 | Faheem Hasnain | C/O Vital Therapies, Inc. 15010 Avenues Of Science, Suite 200 San Diego CA 92128 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-08-12 | 118,243 | $5.92 | 122,743 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Acquisiton | 2016-08-11 | 58,574 | $0.00 | 58,574 | $5.92 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
58,574 | 2026-08-10 | No | 4 | A | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 3,500 | Indirect | By trust |
Footnotes
- Subject to reporting person's continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan) through each vesting date, 1/48th of the shares subject to the option shall vest and become exercisable monthly such that 100% of the shares subject to the option shall be fully vested and exercisable on August 11, 2020.